Previously submitted to: JMIR mHealth and uHealth (no longer under consideration since Mar 29, 2022)
Date Submitted: Oct 24, 2021
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Benefits of mHealth for Symptom Management of Cancer Patients: A Meta-Analysis
ABSTRACT
Background:
At the present, cancer patients are experiencing symptoms that can seriously influence their quality of life. There are many mobile health applications in Internet medical services to manage those symptoms. However, further research is needed to see whether mobile health can provide benefits to cancer patients.
Objective:
The meta-analysis aimed to value the benefits of mHealth for depression, anxiety, pain, fatigue, and insomnia outcomes of cancer patients.
Methods:
We searched PubMed, CINHAL, Web of Science, Cochrane library Trials, EMBASE database to select random clinic trials that investigated the benefits of mHealth for cancer patients, from the date of inception to 17 April 2021.
Results:
Eight random clinic trials were eligible for this meta-analysis. Collectively, mHealth group has 1641 participants, the control group has 1463 participants. The meta-analysis revealed that the mHealth intervention improves significantly cancer patients’ fatigue(SMD −0.19, 95% CI −0.32 to −0.05），P= .007), insomnia(SMD −0.26, 95% CI −0.44 to −0.08, P= .005), depression(SMD −0.22, 95% CI −0.32 to −0.13，P<0.00001), and anxiety(SMD −0.27, 95% CI −0.47 to −0.07, P= .008), whereas no significant difference was found in pain score (SMD -0.27, 95%CI −0.68 to 0.13，P= .19).
Conclusions:
mHealth intervention may significantly improve depression, anxiety, fatigue, and insomnia outcomes of cancer patients, but have no significant effort on pain. Clinical Trial: This meta-analysis was registered with The International Prospective Register of Systematic Reviews (PROSPERO) , registration number is: CRD42021272537.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.